• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Factor H Autoantibodies and Membranous Nephropathy.

作者信息

Seikrit Claudia, Ronco Pierre, Debiec Hanna

机构信息

INSERM UMR S1155, Paris, France

出版信息

N Engl J Med. 2018 Dec 20;379(25):2479-2481. doi: 10.1056/NEJMc1805857.

DOI:10.1056/NEJMc1805857
PMID:30575481
Abstract
摘要

相似文献

1
Factor H Autoantibodies and Membranous Nephropathy.补体因子H自身抗体与膜性肾病
N Engl J Med. 2018 Dec 20;379(25):2479-2481. doi: 10.1056/NEJMc1805857.
2
Serum anti-PLA2R antibodies may be present before clinical manifestations of membranous nephropathy.在膜性肾病临床表现出现之前，血清抗磷脂酶A2受体（PLA2R）抗体可能已经存在。
Kidney Int. 2016 Jun;89(6):1399. doi: 10.1016/j.kint.2015.11.032.
3
Human idiopathic membranous nephropathy--a mystery solved?人类特发性膜性肾病——谜团解开了？
N Engl J Med. 2009 Jul 2;361(1):81-3. doi: 10.1056/NEJMe0903343.
4
Improvement of idiopathic membranous nephropathy diagnosis with ultrasensitive quantitative detection of anti-phospholipase A2 receptor.通过抗磷脂酶A2受体的超灵敏定量检测改善特发性膜性肾病的诊断
J Allergy Clin Immunol. 2017 Jun;139(6):1988-1990.e2. doi: 10.1016/j.jaci.2016.10.020. Epub 2016 Nov 19.
5
Circulating anti-PLA2R autoantibodies to monitor immunological activity in membranous nephropathy.循环抗磷脂酶A2受体自身抗体用于监测膜性肾病的免疫活性。
J Am Soc Nephrol. 2011 Aug;22(8):1400-2. doi: 10.1681/ASN.2011060610. Epub 2011 Jul 22.
6
Clinical characteristics of thrombospondin type-1 domain-containing 7A-associated membranous nephropathy.含血小板反应蛋白1型结构域7A相关膜性肾病的临床特征
Ren Fail. 2020 Nov;42(1):966-968. doi: 10.1080/0886022X.2020.1819318.
7
Development of a standardized ELISA for the determination of autoantibodies against human M-type phospholipase A2 receptor in primary membranous nephropathy.原发性膜性肾病中人 M 型磷脂酶 A2 受体自身抗体的酶联免疫吸附测定法的建立。
Clin Chim Acta. 2013 Jun 5;421:213-8. doi: 10.1016/j.cca.2013.03.015. Epub 2013 Mar 27.
8
Retreatment with rituximab for membranous nephropathy with persistently elevated titers of anti-phospholipase A2 receptor antibody.利妥昔单抗对伴有抗磷脂酶A2受体抗体滴度持续升高的膜性肾病进行再治疗。
Kidney Int. 2019 Jan;95(1):233-234. doi: 10.1016/j.kint.2018.08.045.
9
Anti-phospholipase A2 Receptor Antibody and Immunosuppression in Membranous Nephropathy: More Evidence for Pathogenicity of Anti-phospholipase A2 Receptor Autoantibodies.抗磷脂酶A2受体抗体与膜性肾病的免疫抑制：抗磷脂酶A2受体自身抗体致病性的更多证据
J Am Soc Nephrol. 2015 Oct;26(10):2308-11. doi: 10.1681/ASN.2015020181. Epub 2015 Mar 24.
10
PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy.膜性肾病中的PLA2R自身抗体和PLA2R肾小球沉积物
N Engl J Med. 2011 Feb 17;364(7):689-90. doi: 10.1056/NEJMc1011678.

引用本文的文献

1
Chronic kidney disease enhances alternative pathway activity: a new paradigm.慢性肾脏病增强替代途径活性：一种新范式。
J Clin Invest. 2025 May 1;135(9). doi: 10.1172/JCI188353.
2
Therapeutic targets in membranous nephropathy: plasma cells and complement.膜性肾病的治疗靶点：浆细胞与补体
Clin Kidney J. 2024 Aug 13;17(9):sfae243. doi: 10.1093/ckj/sfae243. eCollection 2024 Sep.
3
A review of progress on complement and primary membranous nephropathy.补体与原发性膜性肾病研究进展述评。
Medicine (Baltimore). 2024 Jul 19;103(29):e38990. doi: 10.1097/MD.0000000000038990.
4
Proteomic analysis of glomeruli, tubules and renal interstitium in idiopathic membranous nephropathy (IMN): A statistically observational study.特发性膜性肾病（IMN）肾小球、肾小管和肾间质的蛋白质组学分析：一项统计学观察性研究。
Medicine (Baltimore). 2023 Dec 15;102(50):e36476. doi: 10.1097/MD.0000000000036476.
5
Kidney diseases.肾脏疾病。
Immunol Rev. 2023 Jan;313(1):239-261. doi: 10.1111/imr.13167. Epub 2022 Nov 12.
6
The role of the complement system in primary membranous nephropathy: A narrative review in the era of new therapeutic targets.补体系统在原发性膜性肾病中的作用：新治疗靶点时代的叙述性综述。
Front Immunol. 2022 Oct 24;13:1009864. doi: 10.3389/fimmu.2022.1009864. eCollection 2022.
7
The Alternative Pathway Is Necessary and Sufficient for Complement Activation by Anti-THSD7A Autoantibodies, Which Are Predominantly IgG4 in Membranous Nephropathy.抗-THSD7A 自身抗体通过替代途径激活补体是必要且充分的，而在膜性肾病中，这些自身抗体主要是 IgG4。
Front Immunol. 2022 Jul 7;13:952235. doi: 10.3389/fimmu.2022.952235. eCollection 2022.
8
Post-Transplant Thrombotic Microangiopathy due to a Pathogenic Mutation in Complement Factor I in a Patient With Membranous Nephropathy: Case Report and Review of Literature.膜性肾病患者因补体因子I致病突变导致的移植后血栓性微血管病：病例报告及文献复习
Front Immunol. 2022 May 26;13:909503. doi: 10.3389/fimmu.2022.909503. eCollection 2022.
9
Safety surveillance of meningococcal group B vaccine (Bexsero®), Vaccine Adverse Event Reporting System, 2015-2018.2015-2018 年脑膜炎球菌 B 型疫苗（Bexsero®）的安全性监测。疫苗不良事件报告系统。
Vaccine. 2022 Jan 21;40(2):247-254. doi: 10.1016/j.vaccine.2021.11.071. Epub 2021 Dec 7.
10
Renal diseases and the role of complement: Linking complement to immune effector pathways and therapeutics.肾脏疾病与补体的作用：将补体与免疫效应途径和治疗联系起来。
Adv Immunol. 2021;152:1-81. doi: 10.1016/bs.ai.2021.09.001. Epub 2021 Nov 19.